Autism Spectrum Disorder Trial, Recruiting NCT06726187 Sponsor: Parnassia Groep Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06726187
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Autism Spectrum Disorder (ASD):

  • People who have a primary diagnosis of Autism Spectrum Disorder (ASD) based on the DSM-5-TR (a standard medical diagnostic guide)
  • People who are 18 years of age or older
  • People who do not have an intellectual disability
  • People who have completed at least primary and secondary school education

For informants (someone who knows the ASD participant well):

  • People who know the ASD participant well and can accurately describe their personality — ideally someone who lives with them, or if not available, the person who knows them best
  • People who have historically spoken with the participant at least once a month and met them in person at least once a year

Who may not be able to join:

For people with ASD:

  • People who do not have a diagnosis of ASD
  • People who are currently experiencing substance abuse issues
  • People who have a psychotic disorder
  • People who have schizophrenia
  • People who have an eating disorder
  • People who have an IQ below 80
  • People who are currently experiencing thoughts of suicide
  • People who are under 18 years of age

For informants:

  • People who are under 18 years of age
  • People who have an intellectual disability
  • People who are not able to describe or recognise the psychological functioning or difficulties of the ASD participant they are connected to

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Parnassia Groep
Registry
ClinicalTrials.gov
Start date
1 March 2024
Est. completion
28 January 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Score SCID-5-PD

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov